Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Cetirizine Stories

2013-09-10 12:28:43

ALLEGAN, Mich., Sept. 10, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for cetirizine hydrochloride oral solution USP, 1 mg/mL, bubble gum flavored, the store brand equivalent to Children's Zyrtec® Allergy Syrup, 1 mg/mL, bubble gum flavored. Perrigo expects to begin shipments of the product during the upcoming cough/cold/flu...

2013-09-03 08:28:53

FORT WASHINGTON, Pa., Sept. 3, 2013 /PRNewswire/ -- The makers of ZYRTEC(®) understand that allergy symptoms not only impact the way allergy sufferers feel, but also how they look. In fact, more than half of the men and women surveyed (54 percent) admit to experiencing allergy-related challenges like watery eyes, a red nose, or a puffy face during fall allergy season.[1] The ZYRTEC(®) Brand has teamed up with actress Debra Messing, as well as beauty experts Rebekah George and Carmen...

2013-03-06 12:26:21

New Survey by the Makers of ZYRTEC ® Reveals Impact of ALLERGY FACE (TM) on Beauty Routines FORT WASHINGTON, Pa., March 6, 2013 /PRNewswire/ -- For the millions of women who deal with allergy symptoms, the face of allergies is not always pretty. According to a recent survey commissioned by the makers of ZYRTEC®[1], 96 percent of women with allergy symptoms suffer from ALLERGY FACE(TM) - the beauty challenges resulting from watery eyes, a red nose, and a puffy face. (Photo:...

2011-11-07 09:24:00

ALLEGAN, Mich., Nov. 7, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) and its partner Synthon Pharmaceuticals, Inc. today announced that Perrigo has begun shipping Levocetirizine Solution, 2.5 mg/5ml, a generic version of UCB's Xyzal® Oral Solution. Synthon has the first to file ANDA application for the generic that entitle it to 180 days of generic exclusivity. Hatch Waxman litigation in this product was settled earlier this year. Perrigo is the manufacturer...

2011-05-18 07:15:00

ALLEGAN, Mich., May 18, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) and its partner Synthon Pharmaceuticals, Inc. today announced that it has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Levocetirizine Solution, 2.5 mg/5ml, a generic version of UCB's Xyzal® Oral Solution. Synthon believes it has a first to file ANDA application for the generic that can entitle it to 180 days of generic...

2011-03-03 05:06:00

MUMBAI, India, March 3, 2011 /PRNewswire-FirstCall/ -- - This Press Release Supersedes and Replaces the Prior Release. Glenmark Generics Inc., USA (GGI), the United States subsidiary of Glenmark Generics Limited (GGL), announced they have been granted final approval for their Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (U.S. FDA) for Levocetirizine Dihydrochloride 5 mg tablets, the generic version of UCB Inc.'s Xyzal(R) tablets....

2010-11-29 08:40:00

ALLEGAN, Mich., Nov. 29, 2010 /PRNewswire-FirstCall/ -- Perrigo (Nasdaq: PRGO;TASE) today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S. The Synthon product is the only...

2010-07-26 08:49:00

ALLEGAN, Mich., July 26 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the Company's fiscal first quarter 2011. Cherry joins the currently available grape flavor cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavors. The product will...

2009-08-25 08:18:00

FT. WASHINGTON, Pa., Aug. 25 /PRNewswire/ -- The makers of ZYRTEC(R), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today announced the availability of two new allergy solutions to help adult and children allergy sufferers this fall allergy season. Children's ZYRTEC(R) PERFECT MEASURE(R) and ZYRTEC(R) Itchy Eye Drops are the most recent in the expanding ZYRTEC(R) portfolio of allergy products. The company also announced the launch of AllergyCast, an iPhone(R) application that...

2009-06-24 09:29:00

ALLEGAN, Mich., June 24 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Synthon Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application (ANDA) for Levocetirizine solution 2.5mg/5ml, a generic version of Xyzal(R) solution 2.5mg/5ml. Under terms of an exclusive agreement between the companies, Perrigo has sales and marketing rights in Synthon's Levocetirizine products. The Company believes that Synthon is the first to file an ANDA...